Answers are grounded in this paper and cite their sources.
Shows real-time genomic risk prediction in breast cancer, indicating a shift towards precision medicine.
Healix BioLabs is an explainable real-time genomic intelligence platform designed for breast cancer risk prediction using AI-driven genomic inference. Built using the GSE42568 NCBI GEO benchmark dataset, Healix operationalizes breast cancer genomic classification into a deployable clinician-facing system featuring: • Real-time genomic upload and inference• Explainable confidence visualization• Gene attribution heatmaps• Clinical interpretation synthesis• Exportable diagnostic reporting• Interactive translational oncology dashboard deployment This work bridges the gap between computational oncology research and real-world precision medicine deployment by transforming static machine-learning workflows into a deployable genomic intelligence infrastructure.
No takes yet. Share an insight, caveat, or question.
Avnish Verma (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: